FTC sues key pharmacy reward supervisors in excess of insulin charges The company brought motion towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list price of daily life-conserving insulin medicine. Earlier this summer season, the business held lengthy negotiations with Steward https://judahrurtu.bloggerbags.com/35835952/the-healthcare-news-diaries